![James Kinley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Kinley
Finanzdirektor/CFO bei
GREY MATTERS HEALTH INC.
Vermögen: 95 004 $ am 31.05.2026
Profil
James F.
Kinley is currently Independent Director at Medicure, Inc. since 2022, Independent Director at Waverley Pharma, Inc. since 2024, Chief Financial Officer at Cytophage Technologies Ltd. starting 2026, Chief Financial Officer & Secretary at Grey Matters Health, Inc. since 2022, and Chief Financial Officer at Algernon Neuroscience, Inc. Formerly, Mr. Kinley was Principal at Ernst & Young LLP, Chief Financial Officer at Medicure, Inc. from 2011 to 2021, Manager at Manitoba Telecom Services, Inc., and Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
Education includes undergraduate studies at Asper School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.12.2025 | 178’992 ( 3.3% ) | 56 740 $ | 31.05.2026 | |
MEDICURE INC. 0.45% | 02.04.2026 | 47’100 ( 0.45% ) | 37 868 $ | 31.05.2026 |
| 05.05.2025 | 56’500 ( 0.1% ) | 396 $ | 31.05.2026 |
Aktive Positionen von James Kinley
| Unternehmen | Position | Beginn |
|---|---|---|
| GREY MATTERS HEALTH INC. | Finanzdirektor/CFO | 01.12.2021 |
| MEDICURE INC. | Direktor/Vorstandsmitglied | 16.06.2022 |
| WAVERLEY PHARMA INC. | Direktor/Vorstandsmitglied | 20.06.2024 |
| CYTOPHAGE TECHNOLOGIES LTD. | Finanzdirektor/CFO | 20.01.2026 |
Algernon Neuroscience, Inc. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von James Kinley
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICURE INC. | Finanzdirektor/CFO | 15.05.2021 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Finanzdirektor/CFO | 18.01.2016 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
| BELL MTS | Corporate Officer/Principal | - |
Ausbildung von James Kinley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Medicure, Inc.
 Medicure, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research, development and commercialization & marketing of human therapeutics products | Health Technology |
Manitoba Telecom Services, Inc.
 Manitoba Telecom Services, Inc. Wireless TelecommunicationsCommunications Provides telecommunications services | Communications |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Asper School of Business
 Asper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
Waverley Pharma, Inc.
 Waverley Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Algernon Neuroscience, Inc. | |
Cytophage Technologies Ltd.
 Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
